지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2023.9
- 수록면
- 627 - 637 (11page)
이용수
초록· 키워드
오류제보하기
Background: Damage to the healthy intestinal epithelial layer and regulation of the intestinal immune system, closely interrelated, are considered pivotal parts of the curative treatment for inflammatory bowel disease (IBD). Plant-based diets and phytochemicals can support the immune microenvironment in the intestinal epithelial barrier for a balanced immune system by improving the intestinal microecological balance and may have therapeutic potential in colitis. However, there have been only a few reports on the therapeutic potential of plant-derived exosome-like nanoparticles (PENs) and the underlying mechanism in colitis. This study aimed to assess the therapeutic effect of PENs from Panax ginseng, ginseng-derived exosome-like nanoparticles (GENs), in a mouse model of IBD, with a focus on the intestinal immune microenvironment.
Method: To evaluate the anti-inflammatory effect of GENs on acute colitis, we treated GENs in Caco2 and lipopolysaccharide (LPS) -induced RAW 264.7 macrophages and analyzed the gene expression of proinflammatory cytokines and anti-inflammatory cytokines such as TNF-a, IL-6, and IL-10 by real-time PCR (RT-PCR). Furthermore, we further examined bacterial DNA from feces and determined the alteration of gut microbiota composition in DSS-induced colitis mice after administration of GENs through 16S rRNA gene sequencing analysis.
Result: GENs with low toxicity showed a long-lasting intestinal retention effect for 48 h, which could lead to effective suppression of pro-inflammatory cytokines such as TNF-a and IL-6 production through inhibition of NF-kB in DSS-induced colitis. As a result, it showed longer colon length and suppressed thickening of the colon wall in the mice treated with GENs. Due to the amelioration of the progression of DSS-induced colitis with GENs treatment, the prolonged survival rate was observed for 17 days compared to 9 days in the PBS-treated group. In the gut microbiota analysis, the ratio of Firmicutes/Bacteroidota was decreased, which means GENs have therapeutic effectiveness against IBD. Ingesting GENs would be expected to slow colitis progression, strengthen the gut microbiota, and maintain gut homeostasis by preventing bacterial dysbiosis.
Conclusion: GENs have a therapeutic effect on colitis through modulation of the intestinal microbiota and immune microenvironment. GENs not only ameliorate the inflammation in the damaged intestine by downregulating pro-inflammatory cytokines but also help balance the microbiota on the intestinal barrier and thereby improve the digestive system.
Method: To evaluate the anti-inflammatory effect of GENs on acute colitis, we treated GENs in Caco2 and lipopolysaccharide (LPS) -induced RAW 264.7 macrophages and analyzed the gene expression of proinflammatory cytokines and anti-inflammatory cytokines such as TNF-a, IL-6, and IL-10 by real-time PCR (RT-PCR). Furthermore, we further examined bacterial DNA from feces and determined the alteration of gut microbiota composition in DSS-induced colitis mice after administration of GENs through 16S rRNA gene sequencing analysis.
Result: GENs with low toxicity showed a long-lasting intestinal retention effect for 48 h, which could lead to effective suppression of pro-inflammatory cytokines such as TNF-a and IL-6 production through inhibition of NF-kB in DSS-induced colitis. As a result, it showed longer colon length and suppressed thickening of the colon wall in the mice treated with GENs. Due to the amelioration of the progression of DSS-induced colitis with GENs treatment, the prolonged survival rate was observed for 17 days compared to 9 days in the PBS-treated group. In the gut microbiota analysis, the ratio of Firmicutes/Bacteroidota was decreased, which means GENs have therapeutic effectiveness against IBD. Ingesting GENs would be expected to slow colitis progression, strengthen the gut microbiota, and maintain gut homeostasis by preventing bacterial dysbiosis.
Conclusion: GENs have a therapeutic effect on colitis through modulation of the intestinal microbiota and immune microenvironment. GENs not only ameliorate the inflammation in the damaged intestine by downregulating pro-inflammatory cytokines but also help balance the microbiota on the intestinal barrier and thereby improve the digestive system.
목차
ABSTRACT
1. Introduction
2. Materials and methods
3. Results and discussion
4. Discussion
5. Conclusion
References
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Context-Dependent Regulation of Type17 Immunity by Microbiota at the Intestinal Barrier
Immune Network
2022 .12
-
Korean Red Ginseng alleviates dextran sodium sulfate-induced colitis through gut microbiota modulation in mice
Journal of Ginseng Research
2024 .11
-
Inflammatory bowel disease pathogenesis mediated by Th17 cells: cytokines, microbiota, and therapies
Journal of Biomedical and Translational Research
2024 .06
-
Immunomodulatory and Anti-Inflammatory Phytochemicals for the Treatment of Inflammatory Bowel Disease (IBD): Turning Strong Rationale into Strong Evidence?
Journal of Pharmacopuncture
2018 .01
-
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Intestinal research
2024 .01
-
Indigo Naturalis in Inflammatory Bowel Disease: mechanisms of action and insights from clinical trials
Journal of Pharmacopuncture
2024 .06
-
Fecal microbiota transplantation in ulcerative colitis
한국실험동물학회 학술발표대회 논문집
2018 .07
-
Day- and dose-dependent inflammatory response and gut microbiota modulation in DSS-induced colitis murine model
한국실험동물학회 학술발표대회 논문집
2020 .02
-
Epithelial-microbial diplomacy: escalating border tensions drive inflammation in inflammatory bowel disease
Intestinal research
2019 .01
-
Gut microbiome and checkpoint inhibitor colitis
Intestinal research
2021 .10
-
The Improving Effect of Gastrodia elata Blume on DSS-induced Colitis in Mice
대한의생명과학회지
2018 .09
-
Gossypetin supressed DSS-induced colitis through p38 signaling pathway
한국실험동물학회 학술발표대회 논문집
2021 .07
-
CM1, a novel chrysin derivative, attenuates inflammatory responses in DSS-induced colitis mice model: Therapeutic potential against inflammatory bowel disease
한국실험동물학회 학술발표대회 논문집
2022 .01
-
Inflammatory bowel disease–associated intestinal fibrosis
Journal of Pathology and Translational Medicine
2023 .01
-
Microbial Modulation in Inflammatory Bowel Diseases
Immune Network
2022 .12
-
장내 미생물과 염증장질환
대한의사협회지
2021 .09
-
Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
Immune Network
2017 .02
-
Amelioration of DSS-Induced Acute Colitis in Mice by Recombinant Monomeric Human Interleukin-22
Immune Network
2022 .06
-
Long-Term Effects of Bone Marrow-Derived Mesenchymal Stem Cells in Dextran Sulfate Sodium-Induced Murine Chronic Colitis
Gut and Liver
2016 .01
-
American ginseng attenuates azoxymethane/dextran sodium sulfate-induced colon carcinogenesis in mice
Journal of Ginseng Research
2015 .07
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-151-24-02-088242375